Literature DB >> 12886172

Measuring patients' perceptions of the outcomes of treatment for early prostate cancer.

Jack A Clark1, Barbara G Bokhour, Thomas S Inui, Rebecca A Silliman, James A Talcott.   

Abstract

BACKGROUND: Compared with careful attention to the physical (eg, urinary, bowel, sexual) dysfunction that may follow treatment, little attention has been given to the behavioral, emotional, and interpersonal changes that the diagnosis of early prostate cancer and subsequent physical dysfunction may bring.
OBJECTIVE: To construct patient-centered measures of the outcomes of treatment for early prostate cancer. RESEARCH
DESIGN: Qualitative study followed by survey of early prostate cancer patients and group of comparable patients with no history of prostate cancer. Analysis of focus groups identified relevant domains of quality of life, which were represented by Likert scale items included in survey questionnaires. Psychometric analyses of survey data defined scales evaluated with respect to internal consistency and validity.
RESULTS: Qualitative analysis identified three domains: urinary control, sexuality, and uncertainty about the cancer and its treatment. Psychometric analysis defined 11 scales. Seven were generically relevant to most older men: urinary control (eg, embarrassment with leakage), sexual intimacy (eg, anxiety about completing intercourse), sexual confidence (eg, comfort with sexuality), marital affection (eg, emotional distance from spouse/partner), masculine self esteem (eg, feeling oneself a whole man), health worry (eg, apprehensiveness about health changes), and PSA concern (eg, closely attending to one's PSA). Four scales were specific to the treatment experience: perceived cancer control, quality of treatment decision making, regret of treatment choice, and cancer-related outlook.
CONCLUSION: The scales provide definition and metrics for patient-centered research in this area. They complement measures of physical dysfunction and bring into resolution outcomes of treatment that have gone unnoticed in previous studies.

Entities:  

Mesh:

Year:  2003        PMID: 12886172     DOI: 10.1097/00005650-200308000-00006

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  42 in total

Review 1.  The importance and complexity of regret in the measurement of 'good' decisions: a systematic review and a content analysis of existing assessment instruments.

Authors:  Natalie Joseph-Williams; Adrian Edwards; Glyn Elwyn
Journal:  Health Expect       Date:  2010-09-23       Impact factor: 3.377

2.  Post-treatment regret among young breast cancer survivors.

Authors:  Sara Fernandes-Taylor; Joan R Bloom
Journal:  Psychooncology       Date:  2011-05       Impact factor: 3.894

3.  Evaluation of quality of life in patients with previously untreated advanced prostate cancer receiving maximum androgen blockade therapy or LHRHa monotherapy: a multicenter, randomized, double-blind, comparative study.

Authors:  Yoichi Arai; Hideyuki Akaza; Takashi Deguchi; Masato Fujisawa; Mikio Hayashi; Yoshihiko Hirao; Hiroshi Kanetake; Seiji Naito; Mikio Namiki; Masaaki Tachibana; Michiyuki Usami; Yasuo Ohashi
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-20       Impact factor: 4.553

4.  Baseline and follow-up association of the MAX-PC in Men with newly diagnosed prostate cancer.

Authors:  Andrea M Tavlarides; Steven C Ames; David D Thiel; Nancy N Diehl; Alexander S Parker
Journal:  Psychooncology       Date:  2014-06-21       Impact factor: 3.894

5.  Factors associated with emotional distress in newly diagnosed prostate cancer patients.

Authors:  Heather Orom; Christian J Nelson; Willie Underwood; D Lynn Homish; Deepak A Kapoor
Journal:  Psychooncology       Date:  2015-01-28       Impact factor: 3.894

6.  Impact of prostate cancer on sexual relationships: a longitudinal perspective on intimate partners' experiences.

Authors:  Scott D Ramsey; Steven B Zeliadt; David K Blough; Carol M Moinpour; Ingrid J Hall; Judith Lee Smith; Donatus U Ekwueme; Catherine R Fedorenko; Megan E Fairweather; Lisel M Koepl; Ian M Thompson; Thomas E Keane; David F Penson
Journal:  J Sex Med       Date:  2013-09-30       Impact factor: 3.802

Review 7.  Quality-of-life assessment tools for men with prostate cancer.

Authors:  Jonathan Bergman; Aaron Laviana
Journal:  Nat Rev Urol       Date:  2014-05-20       Impact factor: 14.432

8.  Mixed methods in biomedical and health services research.

Authors:  Leslie A Curry; Harlan M Krumholz; Alicia O'Cathain; Vicki L Plano Clark; Emily Cherlin; Elizabeth H Bradley
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-01-01

9.  Cancer-related communication, relationship intimacy, and psychological distress among couples coping with localized prostate cancer.

Authors:  Sharon Manne; Hoda Badr; Talia Zaider; Christian Nelson; David Kissane
Journal:  J Cancer Surviv       Date:  2009-12-06       Impact factor: 4.442

10.  The Influence of Psychosocial Constructs on the Adherence to Active Surveillance for Localized Prostate Cancer in a Prospective, Population-based Cohort.

Authors:  Maximilian F Lang; Mark D Tyson; JoAnn Rudd Alvarez; Tatsuki Koyama; Karen E Hoffman; Matthew J Resnick; Matthew R Cooperberg; Xiao-Cheng Wu; Vivien Chen; Lisa E Paddock; Ann S Hamilton; Mia Hashibe; Michael Goodman; Sheldon Greenfield; Sherrie H Kaplan; Antoinette Stroup; David F Penson; Daniel A Barocas
Journal:  Urology       Date:  2017-02-09       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.